| FCANX | HBLCX | FCANX / HBLCX | |
| Total Expense Ratio | 1.52 | 1.65 | 92% |
| Annual Report Gross Expense Ratio | 1.55 | 1.65 | 94% |
| Fund Existence | 19 years | 20 years | - |
| Gain YTD | 5.563 | 3.319 | 168% |
| Front Load | N/A | N/A | - |
| Min. Initial Investment | 0 | 2000 | - |
| Min. Initial Investment IRA | 500 | 2000 | 25% |
| Net Assets | 2.27B | 11.2B | 20% |
| Annual Yield % from dividends | 1.83 | 2.49 | 73% |
| Returns for 1 year | 12.79 | 5.05 | 253% |
| Returns for 3 years | 21.34 | 10.07 | 212% |
| Returns for 5 years | 15.03 | 2.78 | 541% |
| Returns for 10 years | 42.82 | 31.49 | 136% |
| 1 Day | |||
|---|---|---|---|
| ETFs / NAME | Price $ | Chg $ | Chg % |
| ILCG | 117.14 | 2.24 | +1.95% |
| iShares Morningstar Growth ETF | |||
| DUNK | 24.48 | 0.31 | +1.28% |
| Dana Unconstrained Equity ETF | |||
| AIVL | 128.88 | 1.05 | +0.82% |
| WisdomTree US Al Enhanced Val ETF | |||
| ZOCT | 27.59 | 0.04 | +0.15% |
| Innovator Eq Dfnd Prt ETF - 1 Yr Oct | |||
| BIB | 85.02 | 0.07 | +0.08% |
| ProShares Ultra Nasdaq Biotechnology | |||